患者源性抗体减轻复发缓解型多发性硬化小鼠模型的疾病严重程度
本研究从多发性硬化患者中鉴定出重组人抗体TGM-010,该抗体可结合人和小鼠神经元并被内化。在体外应激后保护神经元免于死亡,在复发缓解型EAE小鼠模型中全身给药可改善疾病严重程度并提高神经元存活。提示患者源性抗神经元抗体TGM-010可能用于减轻神经退行性变导致的残疾。
要点
- TGM-010可穿过血脑屏障并内化进入神经元。
- TGM-010在体外保护原代小鼠神经元免于死亡。
- 在复发缓解型EAE小鼠中TGM-010改善疾病严重程度并提高神经元存活。
核心结论
- 患者源性抗神经元自身抗体TGM-010可穿过小鼠血脑屏障并在MS小鼠模型中减少神经元丢失。
研究设计与样本
- 研究鉴定源自多发性硬化患者的重组人抗体TGM-010,并在体外及复发缓解型EAE小鼠模型中评估其作用。
主要发现
- TGM-010可结合人和小鼠神经元并被内化,且能穿过血脑屏障。
- TGM-010在体外保护原代小鼠神经元免受应激后死亡。
- 在复发缓解型EAE小鼠中,TGM-010改善疾病严重程度并与神经元存活改善相关。
临床怎么用
- TGM-010可能作为减轻神经退行性变所致残疾的候选抗体,但尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Naturally occurring autoantibodies are commonly considered to be causative of autoimmune diseases or epiphenomena with no known biological impact. Although clinically beneficial autoantibodies have been described, there have been no naturally occurring anti-neuronal antibodies that have been found to be neuroprotective. Here, we identify a recombinant human antibody (TGM-010) derived from a patient with multiple sclerosis (MS) that binds human and mouse neurons, leading to beneficial effects. METHODS: TGM-010 was examined for its ability to be internalized by human and mouse neurons and protect neurons from death in vitro following a stress event. TGM-010 was also injected systemically into a relapsing-remitting model of experimental autoimmune encephalomyelitis (EAE) to examine its ability to impact disease score, extent of demyelination, and neuron frequency. RESULTS: TGM-010 demonstrates many novel characteristics including crossing the blood-brain barrier (BBB) and internalizing into neurons. TGM-010 also protects primary mouse neurons from death in vitro. In a mouse model of MS, TGM-010 ameliorates disease severity and is associated with improved neuronal survival. INTERPRETATION: This study identified a patient-derived neuron-binding autoantibody that crosses the BBB in mice and reduces neuron loss in a mouse model of MS. These data suggest that the human derived anti-neuronal antibody, TGM-010, may potentially be used to ameliorate neurodegeneration that underlies disability in neurodegenerative conditions. ANN NEUROL 2026;99:1152-1165.
引用
- Smith C, Greenberg BM, Reynolds J, et al. A Patient-Derived Antibody Ameliorates Disease Severity in a Relapsing Remitting Murine Model of Multiple Sclerosis. Ann Neurol. 2026. PMID: 41517956. doi:10.1002/ana.78149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。